Kemmeren JM, Algra A, Grobbee DE (University Medical Center Utrecht, Utrecht, The
Netherlands). Effect of second and third generation oral contraceptives on lipid metabolism …

Objective To assess the frequency of factor V Leiden in oral contraceptive users and to
define possible anamnestic data that could predict the presence of factor V Leiden. Methods …

Compared to second generation, the use of third generation oral contraceptives has been
associated with an increased risk of venous thrombosis especially in women with the factor …

The risk of venous thromboembolism in a population not using oral contraceptives (OCs) is
about 11 per 100 000 women-years, among OC users it is about 30-401s2. A carrier of the …

It has been evident for over 30 years that combined oral contraceptive pills (OCP) increase
the risk of venous thromboembolism. Recently, it has been suggested that there is an …

Background Major concern was raised by an earlier study regarding oral contraceptive use
in women with the factor V Leiden mutation. A more than 30-fold increase in relative risk for …

Recent concern about the safety of combined oral contraceptives (OCs) with third-
generation progestagens prompted an examination of data from a population-based case …

We investigated whether the occurrence of venous thrombosis in young women who use
oral contraceptives might be explained by the factor V Leiden mutation, which leads to …

Objective: To evaluate the cost-effectiveness of screening for factor V Leiden mutation in
women in the United States who use combination oral contraceptives. Design: Cost …

Third-generation oral contraceptives (OC) have been associated with an increased risk of
venous thrombosis compared with second-generation OC. To find an explanation for this …